China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Nalbuphine Combined with Remifentanil Multi-Mode Analgesia on Gastrointestinal Function after Traumatic Brain Injury'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129605

Registration Time: 2026/08/06

Type: Interventional study

Primary Sponsor: Shanghai Pudong New Area Gongli Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=305954

Published by HT Digital Content Services with permission from Health Daily Digest....